Dolby Laboratories, Inc.
DLB · NYSE
9/26/2025 | 9/30/2024 | 9/27/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $256,492 | – | $264,316 | $201,644 |
| Dep. & Amort. | $98,597 | – | $87,327 | $95,514 |
| Deferred Tax | $4,988 | – | -$21,612 | -$18,337 |
| Stock-Based Comp. | $128,514 | – | $119,825 | $118,486 |
| Change in WC | -$17,012 | – | -$118,711 | -$47,084 |
| Other Non-Cash | $619 | – | -$3,893 | $16,858 |
| Operating Cash Flow | $472,198 | – | $327,252 | $367,081 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$36,348 | – | -$30,007 | -$30,339 |
| Net Acquisitions | -$1,362 | – | -$487,877 | $25,703 |
| Inv. Purchases | -$75 | – | -$160,198 | -$172,955 |
| Inv. Sales/Matur. | $15,911 | – | $391,790 | $231,797 |
| Other Inv. Act. | $11,288 | – | $0 | $0 |
| Investing Cash Flow | -$10,586 | – | -$286,292 | $54,206 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | – | $0 | $0 |
| Stock Issued | $43,697 | – | $40,203 | $47,781 |
| Stock Repurch. | -$162,228 | – | -$199,076 | -$180,420 |
| Dividends Paid | -$126,599 | – | -$114,579 | -$103,407 |
| Other Fin. Act. | -$2,108 | – | -$14,362 | -$766 |
| Financing Cash Flow | -$247,238 | – | -$287,814 | -$236,812 |
| Forex Effect | $1,235 | – | $6,640 | $5,120 |
| Net Chg. in Cash | $215,609 | – | -$240,214 | $189,595 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $577,752 | – | $817,966 | $628,371 |
| End Cash | $793,361 | – | $577,752 | $817,966 |
| Free Cash Flow | $430,257 | – | $297,245 | $336,742 |